Tyra Biosciences appoints Ashar as COO, Faulds as CRO

Tyra Biosciences (TYRA) announced the appointment of two key members of its leadership team: Bhavesh Ashar as Chief Operating Officer, COO, and Heather Faulds as Chief Regulatory Officer, CRO. Together, Ashar and Faulds will be essential in advancing oral dabogratinib through global Phase 2 studies in skeletal dysplasia and urologic cancers and preparing for potential future pivotal Phase 3 studies. Ashar’s appointment is effective immediately and Faulds’s appointment is effective December 8, 2025.